GlassScriptPhysician profile
David J Korn
NPI 1922082544
$1,655.48
in general payments reported to CMS, 2019-2025
17 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $195 · 2021: $276 · 2022: $363 · 2023: $228 · 2024: $215 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $270.73 | 2023-2025 | |
| Novo Nordisk INC | $234.55 | 2019-2024 | Wegovy |
| Lilly USA, LLC | $213.46 | 2020-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.46 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $177.45 | 2019-2024 | Breztri |
| Exact Sciences Corporation | $134.57 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Philips North America LLC | $97.97 | 2022 | |
| Glaxosmithkline, LLC. | $67.65 | 2021-2023 | Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $52.60 | 2021-2022 | |
| Allergan, INC. | $50.00 | 2019 | |
| Amgen INC. | $36.91 | 2019-2023 | Repatha |
| Esperion Therapeutics, INC. | $30.51 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $29.00 | 2021 | |
| Pfizer INC. | $18.02 | 2021 | |
| Vivus LLC | $17.25 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.68 | 2019 | |
| Merck Sharp & Dohme LLC | $15.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Korn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.